Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (671-680 of 1,253) with videos related to

Pageof 126
Sort By:
Heart (British Cardiac Society)|September 6, 2006
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programmeN M Hawkins, D Wang, J J V McMurray, et al.
Journal of the American College of Cardiology|April 25, 2009
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionPaul W Armstrong, Yuling Fu, Cynthia M Westerhout, et al.
The American Journal of Cardiology|October 26, 2001
Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogramY Birnbaum, S Goodman, A Barr, et al.
The Canadian Journal of Cardiology|November 7, 2000
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigatorsW C Chang, Y Fu, E M Ohman, et al.
Open Heart|November 30, 2018
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trialRoopinder K Sandhu, Justin A Ezekowitz, Ziad Hijazi, et al.
Circulation|July 1, 1997
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic InvestigatorsR Q Migrino, J B Young, S G Ellis, et al.
Journal of the American College of Cardiology|February 20, 2016
Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDRRashmee U Shah, James A de Lemos, Tracy Y Wang, et al.
Journal of the American Heart Association|September 1, 2020
Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial FibrillationZiad Hijazi, Christopher B Granger, Stefan H Hohnloser, et al.
Diabetes, Obesity & Metabolism|February 6, 2024
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trialMatthew P Gilbert, Joan Skelly, Adrian F Hernandez, et al.
American Heart Journal|November 27, 2019
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HFAdam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
Pageof 126

Showing results (671-680 of 1,253) with videos related to

Sort By:
Pageof 126
Heart (British Cardiac Society)|September 6, 2006
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programmeN M Hawkins, D Wang, J J V McMurray, et al.
Journal of the American College of Cardiology|April 25, 2009
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionPaul W Armstrong, Yuling Fu, Cynthia M Westerhout, et al.
The American Journal of Cardiology|October 26, 2001
Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogramY Birnbaum, S Goodman, A Barr, et al.
The Canadian Journal of Cardiology|November 7, 2000
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigatorsW C Chang, Y Fu, E M Ohman, et al.
Open Heart|November 30, 2018
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trialRoopinder K Sandhu, Justin A Ezekowitz, Ziad Hijazi, et al.
Circulation|July 1, 1997
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic InvestigatorsR Q Migrino, J B Young, S G Ellis, et al.
Journal of the American College of Cardiology|February 20, 2016
Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDRRashmee U Shah, James A de Lemos, Tracy Y Wang, et al.
Journal of the American Heart Association|September 1, 2020
Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial FibrillationZiad Hijazi, Christopher B Granger, Stefan H Hohnloser, et al.
Diabetes, Obesity & Metabolism|February 6, 2024
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trialMatthew P Gilbert, Joan Skelly, Adrian F Hernandez, et al.
American Heart Journal|November 27, 2019
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HFAdam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
Pageof 126